Skip to content

Resolution on the upcoming European Research Area (ERA) Act

B10-0156/2026 – Motion for a resolution (as a whole)

10 March 2026 European Parliament - EP-10 RSP 2025/2951(RSP) (OEIL)

Summary

The European Parliament adopted by 399 votes to 78, with 69 abstentions, a resolution on the upcoming European Research Area (ERA) Act.

The EU still lacks an integrated European Research Area (ERA) that attracts and retains talent, owing to barriers such as inadequate prioritisation of research and innovation (R&I) investment, with few Member States meeting the 3 % of GDP target, insufficient R&I policy coordination, continued fragmentation, performance disparities, and excessive administrative burdens for researchers and universities. The ERA Act represents a key opportunity to elevate European research by addressing such challenges.

Parliament supported aligning EU and national R&I priorities to ensure complementarity, increase cooperation between universities, research organisations, regions, Member States and industries, create an effective governance framework, make research careers and private investment more attractive.

Members called for a two-track approach of voluntary cooperation under the ERA Policy Agenda 2025-2027 combined with legislative measures, including the ERA Act and complementary initiatives, to provide ERA with a binding and enforceable framework.

Furthermore, the resolution recommended that the ERA Act be a regulation, ensuring direct applicability across Member States, stimulating private investment in R&D, the free circulation of researchers, scientific knowledge and technology, and contribute to reducing single market fragmentation. Members also called for the ERA Act proposal to be accompanied by a separate legislative proposal with a distinct legal basis protecting the fundamental freedom of scientific research, including minimum standards for researchers’ rights, ethical conduct, integrity and institutional independence, and supported by effective monitoring mechanisms.

Against this background, Parliament also called:

- for the ERA Act to include the Union target of investing at least 3 % of Union GDP in R&D by 2030, complemented by national targets for total R&D expenditure;

- for increased support for public research by strengthening funding for European programmes such as Horizon Europe;

- on Member States to: (i) improve coordination of R&D investment through national roadmaps and targets to ensure complementarity of public and private funding; (ii) increase financial resources for universities and public research organisations; and (iii) undertake reforms to remove barriers to the free circulation of researchers and knowledge, and to enhance cross-border collaboration and innovation. In this regard, it reiterated support for a European Charter for Researchers;

- for strengthened governance of the ERA, and for existing policy and monitoring instruments to be rationalised;

- on the Commission and the Member States to enhance coordination between national and EU R&I initiatives in line with overarching ERA priorities, ensuring synergies across national and Union funding instruments and policies to strengthen Europe’s global scientific and technological leadership.

Lastly, Parliament recommended that the ERA Act be aligned with existing and future initiatives, such as the Innovation Act, the Pact for R&I, the Framework Programme and the European Education Area, to ensure mutually reinforcing reforms, innovation uptake, talent mobility and funding.

Text adopted by Parliament, single reading

Breakdown by Political Group

PPE
136
22
159 members
S&D
112
14
126 members
ECR
32
9
25
71 members
RENEW
54
8
62 members
PFE
43
11
22
81 members
GREENS
42
6
48 members
GUE
10
22
8
42 members
NI
8
3
11
5
27 members
ESN
20
3
23 members

Breakdown by Country

Germany
55 / 11 / 7
Italy
56 / 1 / 7
France
32 / 22 / 4
Poland
14 / 4 / 17
Spain
34 / 0 / 6
Netherlands
20 / 5 / 2
Romania
22 / 0 / 2
Belgium
11 / 3 / 1
Portugal
14 / 3 / 1
Austria
12 / 5 / 0
Greece
7 / 3 / 6
Czechia
15 / 1 / 1
Sweden
14 / 3 / 2
Bulgaria
7 / 3 / 1
Hungary
7 / 7 / 0
Finland
7 / 1 / 2
Denmark
11 / 2 / 0
Ireland
8 / 0 / 2
Slovakia
5 / 2 / 4
Lithuania
8 / 1 / 0
Croatia
10 / 0 / 0
Latvia
4 / 1 / 3
Slovenia
8 / 0 / 0
Luxembourg
5 / 0 / 0
Malta
4 / 0 / 0
Cyprus
4 / 0 / 1
Estonia
5 / 0 / 0

Individual MEP Votes

78 MEPs
MEP Country Group Position
Jean-Paul GARRAUD France PFE Against
Petras GRAŽULIS Lithuania ESN Against
Catherine GRISET France PFE Against
Roman HAIDER Austria PFE Against
Gerald HAUSER Austria PFE Against
György HÖLVÉNYI Hungary PFE Against
Virginie JORON France PFE Against
Alexander JUNGBLUTH Germany ESN Against
Mary KHAN Germany ESN Against
Vilis KRIŠTOPANS Latvia PFE Against

Written Explanations of Vote

1 explanations

Concordo com o princípio geral enunciado na primeira parte da emenda, nomeadamente a importância de assegurar o pleno respeito pelos princípios éticos e pelos direitos humanos nos programas de financiamento da União Europeia e nas parcerias internacionais no domínio da investigação. Contudo, não acompanho a aplicação genérica e excessivamente abrangente proposta na segunda parte da alteração, que prevê a exclusão indiscriminada de universidades e empresas israelitas de todos os programas de investigação financiados pela União Europeia. Uma medida desta natureza penaliza de forma transversal instituições académicas, investigadores e setores científicos que não podem ser responsabilizados coletivamente por decisões políticas ou militares. Por essa razão, e apesar de concordar com o princípio geral invocado, optei pela abstenção nesta votação.